Ebola outbreak: When will a vaccine be developed for the new strain?
Key takeaways
- The Bundibugyo strain of Ebola has a fatality rate of up to 50 percent and no approved vaccine as yet.
- xwhatsapp-strokecopylinkgoogle Add Al Jazeera on Googleinfo.
- No vaccine or treatment exists for the new Bundibugyo strain of Ebola, a disease whose strains have killed more than 15,000 people in Africa in the past half-century.
Why this matters: an international story with cross-border implications worth tracking.
The Bundibugyo strain of Ebola has a fatality rate of up to 50 percent and no approved vaccine as yet.
xwhatsapp-strokecopylinkgoogle Add Al Jazeera on Googleinfo. A health worker takes the temperature of a woman in Goma, North Kivu province, Democratic Republic of the Congo [Arlette Bashizi/Reuters]By Priyanka Shankar Published On 21 May 202621 May 2026The World Health Organization (WHO) has declared that the latest outbreak of a rare strain of the Ebola virus in Democratic Republic of the Congo (DRC) and Uganda is a “public health emergency of international concern”.
No vaccine or treatment exists for the new Bundibugyo strain of Ebola, a disease whose strains have killed more than 15,000 people in Africa in the past half-century. The previous Ebola outbreak in West Africa, which lasted between 2013 and 2016, killed at least 11,000 people, according to the National Library of Medicine.